AstraZeneca sees years of growth as drug sales turn corner - PharmaLive (press release)

 
 
AstraZeneca sees years of growth as drug sales turn cornerPharmaLive (press release)icon_facebook · icon_twitter · icon_linkedin · icon_rss · Marketing & Advertising · R&D · Therapeutics · Resources · Manny Awards · Events · Issue Archives · Login · Advertise · PharmaLive > Business > Financials > AstraZeneca sees years of growth as ...and more »
 
Related NewsFeeds

Titan Pharmaceuticals: 3Q Earnings SnapshotDanbury News TimesSAN FRANCISCO (AP) _ Titan Pharmaceuticals Inc. (TTNP) on Wednesday reported a loss of $2 million in its third quarter. The San Francisco-b

5 visits

Yahoo FinanceCan These 2 Battered Biotech Stocks Recover?Yahoo FinanceDeveloping new cancer therapies is such a risky business that it doesn't take much to send investors running for the hills. Ov

0 visits

STATBiotech is looking woozy: Ferocious selling and a sense of forebodingSTATIt would be funny if not for the pain biotech investors are experiencing. The closely watched basket of biotech stocks call

0 visits

Motley FoolThis Small-Cap Biotech is Quietly Setting the Stage For a Big 2019Motley Fool... is on pace to become the first synthetic biology-focused business to deliver consistent operating profits. T

0 visits

CURE New Issue Alert: Fall 2018Curetoday.comFor example, diarrhea is common in patients who are on VEGF inhibitors or tyrosine kinase inhibitors (TKIs). Diarrhea also occurs in patients who are taking

0 visits

Foamix Pharmaceuticals: Buy, Sell, Or Hold?Seeking AlphaToday, we put Israeli-based Foamix Pharmaceuticals in the spotlight as it has been in the news recently. The company's pipeline has multiple

0 visits

Forensic Technology Global Market Analysis, Growth, Opportunities, Top Key Players and Forecast to 2025Digital JournalPolymerase Chain Reaction (PCR) Capillary Electrophoresis Next-Generation Sequenci

0 visits

Merck drug Keytruda succeeds in late-stage esophageal cancer trialPharmaLive (press release)PharmaLive. Slogan. The Pulse of the Pharmaceutical Industry. icon_facebook · icon_twitter · icon_linkedin ·

3 visits

New Jersey Sues Janssen Over Two Opioid DrugsPharmaLive (press release)PharmaLive. Slogan. The Pulse of the Pharmaceutical Industry. icon_facebook · icon_twitter · icon_linkedin · icon_rss · Marketing

3 visits

AbbVie's Mavyret Demonstrates Sky-High Cure Rates in Hepatitis CPharmaLive (press release)PharmaLive. Slogan. The Pulse of the Pharmaceutical Industry. icon_facebook · icon_twitter · icon_linkedin

3 visits

AbbVie's Mavyret Shows Sky-High Hep C Cure RatesPharmaLive (press release)icon_facebook · icon_twitter · icon_linkedin · icon_rss · Marketing & Advertising · R&D · Therapeutics · Resources · Manny

0 visits

Cutting-edge biotech Sangamo stock dives 13% after JPMorgan cites 'growing skepticism' in downgradeMarketWatchThe biotechnology company Sangamo Therapeutics Inc. is at the cutting edge of the

0 visits

NasdaqAlnylam Pharmaceuticals is Now Oversold (ALNY)NasdaqIn trading on Wednesday, shares of Alnylam Pharmaceuticals Inc (Symbol: ALNY) entered into oversold territory, hitting an RSI reading of 29.2,

0 visits

Wasatch Advisors Inc. Sells 7,944 Shares of China Biologic ...Fairfield CurrentWasatch Advisors Inc. lessened its holdings in China Biologic Products Holdings Inc (NASDAQ:CBPO) by 2.8% during the 3rd

0 visits

The Miami TimesDiabetes' perfect stormThe Miami TimesA recent study revealed that diabetes is the country's most expensive disease. "Diabetes costs the U.S. economy over $327 billion per year,

0 visits

The Pharma LetterAsthma biologic prices 'far out of alignment' with benefit, says ICERThe Pharma LetterThe report assesses the comparative clinical effectiveness and value of biologic treatmen

0 visits

Imprimis Pharmaceuticals and Eyenovia among healthcare gainers; Madrigal Pharmaceuticals leads the losersSeeking AlphaGainers: Eyenovia (NASDAQ:EYEN) +24%. Imprimis Pharmaceuticals (NASDAQ:IMMY) +17%.

0 visits

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (press release) (blog)Diabetes Prevention, Care, and Education in the Digital AgeNational Institute of Diabetes and Digestive a

0 visits

In-PharmaTechnologist.comPharma could have 'immense influence' in combatting the opioid crisis, says expertIn-PharmaTechnologist.comThe US opioid crisis has been driven by early use in standar

0 visits

Republican EagleViewpoint: Eating well for diabetesRepublican EagleAndrew Akhaphong is a registered dietitian, precision nutrition sports coach and an ACTION certified personal trainer for Walker Meth

0 visits